BriaCell Therapeutics (BCT) News Today C$10.60 -0.42 (-3.81%) As of 12/30/2021 Add Compare Share Share Headlines Stock AnalysisBuy This Stock BCT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal4 hours ago | finance.yahoo.comBriaCell Therapeutics Slide After Equity OfferJuly 15, 2025 | marketwatch.comBriaCell Therapeutics Announces Pricing of $15 million Public OfferingJuly 15, 2025 | finance.yahoo.comBriaCell’s Bria-IMT™ Demonstrates Survival ... - Seeking AlphaJuly 13, 2025 | seekingalpha.comBriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy ...July 13, 2025 | morningstar.comMBriaCell Therapeutics Corp.: BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS Metastatic Breast Cancer StudyJuly 9, 2025 | finanznachrichten.deBriaCell Therapeutics stock tumbles after announcing public offeringJuly 9, 2025 | au.investing.comHere's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn SituationJune 25, 2025 | finance.yahoo.comTSX up Near 190 Points at Midday, With Miners, Healthcare, Leading GainsApril 24, 2025 | msn.comBriaCell Therapeutics stock soars on lung metastasis treatment successApril 24, 2025 | investing.comBriaCell's Bria-OTS shows sustained success against breast cancerApril 24, 2025 | msn.comBriaCell Therapeutics Corp.: BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast CancerApril 16, 2025 | finanznachrichten.deBriaCell Therapeutics Stock Rises on Data for Late Stage Breast Cancer TreatmentApril 16, 2025 | marketwatch.comBriaCell Therapeutics Corp.: BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTSFebruary 3, 2025 | finanznachrichten.deBriaCell immunotherapy destroys metastatic breast cancer tumorFebruary 3, 2025 | msn.comBriaCell Showcases Promising Cancer Treatment ResultsDecember 14, 2024 | markets.businessinsider.comBriaCell Shows Promising Survival Data in Cancer TrialDecember 11, 2024 | markets.businessinsider.comBriaCell Highlights Promising Breast Cancer Trial ResultsNovember 27, 2024 | markets.businessinsider.comBriaCell Advances Cancer Treatment with New TrialNovember 22, 2024 | markets.businessinsider.comBriaCell begins phase 1/2 trial of Bria-OTS™ for breast cancerNovember 21, 2024 | msn.comBriaCell Shows Promise in Cancer Immunotherapy AdvancesNovember 9, 2024 | markets.businessinsider.comBriaCell Therapeutics Confronts Financial Challenges Amid Volatile Markets and Potential Shareholder DilutionOctober 31, 2024 | markets.businessinsider.comBriaCell’s Promising Breast Cancer Study ResultsOctober 22, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival DataOctober 22, 2024 | finanznachrichten.deBriaCell Therapeutics advances Phase 3 MBC clinical studyOctober 16, 2024 | msn.comBCT:CA BriaCell Therapeutics Corp.September 21, 2024 | seekingalpha.comBriaCell Therapeutics Corp. (BCTXW)September 18, 2024 | ca.finance.yahoo.comBriaCell Says FDA Authorizes Expanded Access Policy For Patients With Metastatic Breast CancerSeptember 18, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast CancerSeptember 11, 2024 | finanznachrichten.deBriaCell Therapeutics Shares Double on Positive Trial News for Breast Cancer TreatmentSeptember 11, 2024 | marketwatch.comBriaCell Reports Positive OS Data Of Its Phase 2 Clinical Study Of Bria-IMT In Breast CancerSeptember 11, 2024 | markets.businessinsider.comBriaCell Therapeutics Corp.: BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate CancerSeptember 10, 2024 | finanznachrichten.deBriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+(TM) for Prostate CancerSeptember 10, 2024 | stockhouse.comStocks in play: BriaCell Therapeutics Corp.September 9, 2024 | ca.finance.yahoo.comBriaCell Therapeutics Corp. (BCT.TO)February 29, 2024 | ca.finance.yahoo.comBriaCell shares rise on strong data from breast cancer treatment studyFebruary 7, 2024 | msn.comBriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseFebruary 7, 2024 | markets.businessinsider.comBriaCell Shares Advance as Production of Lead Candidate BeginsFebruary 6, 2024 | marketwatch.comBriaCell Therapeutics Corp.: BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsDecember 28, 2023 | finanznachrichten.deBriaCell's Bria-IMT Regimen Shows 71% Intracranial ORR In Breast Cancer PatientsDecember 28, 2023 | markets.businessinsider.comBriaCell Therapeutics Reports Preliminary Survival Benefit Data In Bria-IMT RegimenDecember 20, 2023 | markets.businessinsider.comHere's Why We're Watching BriaCell Therapeutics' (TSE:BCT) Cash Burn SituationDecember 1, 2023 | finance.yahoo.comBriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNovember 3, 2023 | finance.yahoo.comClosing Bell: Briacell Therapeutics Corp flat on Tuesday (BCT)October 18, 2023 | theglobeandmail.comBriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT(TM) in Advanced Breast CancerOctober 6, 2023 | stockhouse.comBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in Advanced Metastatic Breast CancerOctober 3, 2023 | finance.yahoo.comClosing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)September 27, 2023 | theglobeandmail.comBriaCell Therapeutics (BCT) Initiated with a Buy at H.C. WainwrightSeptember 8, 2023 | markets.businessinsider.comClosing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)August 17, 2023 | theglobeandmail.comBriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS™ Immunotherapy for CancerAugust 16, 2023 | finance.yahoo.com Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCT Media Mentions By Week BCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCT News Sentiment▼0.000.70▲Average Medical News Sentiment BCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCT Articles This Week▼00▲BCT Articles Average Week Get the Latest News and Ratings for BCT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Fennec Pharmaceuticals News Theratechnologies News Oncolytics Biotech News Medicenna Therapeutics News Helix BioPharma News Aptose Biosciences News Covalon Technologies News Sernova News Microbix Biosystems News Devonian Health Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:BCT) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access